TY - JOUR T1 - KU135, a Novel Novobiocin-derived C-terminal Inhibitor of Hsp90, Exerts Potent Antiproliferative Effects in Human Leukemic Cells JF - Molecular Pharmacology JO - Mol Pharmacol DO - 10.1124/mol.109.058545 AU - Shary N Shelton AU - Mary E Shawgo AU - Shawna B Comer AU - Yuanming Lu AU - Alison C Donnelly AU - Kristen Szabla AU - Mehmet Tanol AU - George A Vielhauer AU - Roger A Rajewski AU - Robert L Matts AU - Brian S J Blagg AU - John D Robertson Y1 - 2009/09/09 UR - http://molpharm.aspetjournals.org/content/early/2008/12/31/mol.109.058545.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -